ImpediMed Limited
Underestimation
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| P/E |
0/10
|
0 | 31.46 | -100% | -5.84 | -100% |
| P/S |
|
19.25 | 3.24 | 494.34% |
|
|
| P/BV |
|
4.75 | 3.36 | 41.42% |
|
|
| P/FCF |
|
0 | 21.26 | -100% |
|
|
| Ev/Ebitda |
|
-7.71 | 9.95 | -177.48% |
|
|
| Ev/S |
|
16.91 | 1.89 | 794.24% |
|
|
| Ev/FCF |
|
-8.14 | 19.93 | -140.83% |
|
|
| E/P |
|
0 | 1.47 | -100% |
|
|
Efficiency
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Ebitda margin |
0/10
|
-219.35 | 24.35 | -1000.96% | -251.66 | -12.84% |
| ROE |
|
-29.97 | 13.19 | -327.22% |
|
|
| ROA |
|
-26.37 | 6.14 | -529.68% |
|
|
| ROIC |
|
0 | 15.56 | -100% |
|
|
| ROS |
|
-196.86 | 12.56 | -1667.43% |
|
|
| ROCE |
|
-57.42 | 14.36 | -499.91% |
|
|
Debt
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Debt/Ebitda |
10/10
|
-0.0518 | 6.21 | -100.83% | -0.0411 | +26.11% |
| Nеt Debt/Ebitda |
|
1.07 | -5.72 | -118.61% |
|
|
| Debt/Ratio |
|
0.0243 | 0.2122 | -88.53% |
|
|
| Debt/Equity |
|
0.3906 | 12.45 | -96.86% |
|
|
| Debt/Net Income |
|
-0.0578 | 15.05 | -100.38% |
|
|
Dividends
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Dividend yield |
0/10
|
0 | 1.72 | -100% | 0 | 0% |
| Number of years of dividend growth |
|
0 | 1.27 | -100% | ||
| DSI |
|
0 | 0.7793 | -100% |
|
|
| Average dividend growth |
|
0 | -270.17 | -100% |
|
|
| Average percentage for 5 years |
|
0 | 2.79 | -100% |
|
|
| Average percentage for payments |
|
0 | 246.79 | -100% |
|
|
| Difference from average difference in sector |
|
-1.72 |
Growth impulse
| Parameter | Grade | Value | Sector average | Difference with sector, % | ||
|---|---|---|---|---|---|---|
| Growth impulse Revenue in 5 years |
8/10
|
76.55 | 140.59 | -45.55% | ||
| Growth impulse Ebitda in 5 years |
|
-8.58 | 107.17 | -108.01% | ||
| Growth impulse Net Income in 5 years |
|
-7.42 | 123.16 | -106.02% | ||
| Growth impulse FCF in 5 years |
|
-2.27 | 93.68 | -102.42% | ||
| Growth impulse EPS in 5 years |
|
-52.48 | 229.02 | -122.92% |
IP Score
2.97/10
